Showing results (91-100 of 125) with videos related to
Sort By:
Pageof 13
Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.Cancer Discovery|October 31, 2020
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor ResponseMeagan Montesion, Karthikeyan Murugesan, Dexter X Jin, et al.Plos One|March 16, 2022
Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumorsCoren A Milbury, James Creeden, Wai-Ki Yip, et al.Journal of Hematology & Oncology|November 8, 2018
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumorsCathy Zhou, Zilong Yuan, Weijie Ma, et al.Molecular Cancer Therapeutics|March 11, 2014
Concordance of genomic alterations between primary and recurrent breast cancerFunda Meric-Bernstam, Garrett M Frampton, Jaime Ferrer-Lozano, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 26, 2019
Clinical and Immunological Implications of Frameshift Mutations in Lung CancerYoung Kwang Chae, Pedro Viveiros, Gilberto Lopes, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2017
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic ProfilingAlexa B Schrock, Shuyu D Li, Garrett M Frampton, et al.Genome Medicine|April 20, 2017
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burdenZachary R Chalmers, Caitlin F Connelly, David Fabrizio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2016
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular TestingAlexa B Schrock, Garrett M Frampton, Dana Herndon, et al.Cell|January 19, 2011
Densely interconnected transcriptional circuits control cell states in human hematopoiesisNoa Novershtern, Aravind Subramanian, Lee N Lawton, et al.Pageof 13